Skip to content

Travere Therapeutics, Inc. TVTX Total Current Assets

Total Current Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$11.73B+17.2%
LQD
Liquidia CorporationLQDA
$333.06M+87.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.24B+78.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.25B-2.7%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$608.21M-29.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$940.39M+37.1%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s total current assets?
Travere Therapeutics, Inc. (TVTX) reported total current assets of $392.68M in Q1 2026.
How has Travere Therapeutics, Inc.'s total current assets changed year-over-year?
Travere Therapeutics, Inc.'s total current assets increased by 4.9% year-over-year, from $374.17M to $392.68M.
What is the long-term trend for Travere Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s total current assets has grown at a 1.3% compound annual growth rate (CAGR), from $410.41M to $437.57M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.